Iron, TIBC, and Transferrin Saturation by Decade of Life: What the Numbers Actually Mean

Why a Single "Normal Range" Misleads Clinicians

Reference intervals printed on lab reports were built from healthy-volunteer populations that often skew young, male, and White. They tell you where 95% of a reference group falls, not where you want your patient to be. Serum iron alone is unreliable because it fluctuates by up to 30% across a single day and drops sharply during acute illness or inflammation. [1]

The Three-Marker Trio

The iron panel has three moving parts.

Serum iron measures the amount of iron bound to transferrin in plasma. It is drawn fasting, ideally in the morning, because a meal can transiently raise values by 20 to 30 mcg/dL.

TIBC (total iron-binding capacity) reflects the maximum amount of iron transferrin could carry if fully saturated. When iron stores are low, the liver synthesizes more transferrin, so TIBC rises. When iron is abundant or inflammation suppresses transferrin production, TIBC falls. [2]

Transferrin saturation (TSAT) is simply (serum iron ÷ TIBC) × 100. It is the single most sensitive first-line marker for hereditary hemochromatosis screening according to the American Association for the Study of Liver Diseases (AASLD) 2022 practice guidance, which states: "A fasting transferrin saturation greater than 45% in a patient with elevated ferritin should prompt HFE gene testing." [3]

Why Context Beats Cutoffs

None of these three numbers means much without ferritin and a C-reactive protein (CRP). A TSAT of 18% with a ferritin of 8 ng/mL and a CRP of 0.4 mg/L is straightforward iron deficiency. The same TSAT with a ferritin of 120 ng/mL and a CRP of 28 mg/L is anemia of chronic disease, and giving oral iron will accomplish little. [4]

Iron Panel Interpretation in Childhood (Ages 0 to 10)

Children have the highest iron requirements per kilogram of body weight of any age group outside pregnancy, driven by rapid growth and expanding red cell mass. The Centers for Disease Control and Prevention (CDC) recommends universal hemoglobin screening at 9 to 12 months and selective iron-status screening in high-risk toddlers. [5]

Reference Ranges in the First Decade

Serum iron in healthy infants aged 6 to 24 months typically runs 40 to 100 mcg/dL, lower than adult ranges. TIBC in this group is often 250 to 400 mcg/dL. A TSAT below 12% in a toddler is a reliable signal of iron deficiency anemia risk, particularly when accompanied by a mean corpuscular volume (MCV) below 70 fL. [6]

A large cross-sectional analysis of NHANES data (N=7,346 children aged 1 to 5 years) found that 7.1% of toddlers aged 1 to 2 years had iron deficiency defined by two or more abnormal iron markers, with the highest prevalence in low-income and non-Hispanic Black children. [6]

Practical Threshold in Pediatrics

The American Academy of Pediatrics (AAP) defines iron deficiency in children as a TSAT below 10 to 12% combined with a ferritin below 12 ng/mL. Oral ferrous sulfate at 3 to 6 mg/kg/day of elemental iron for 3 months is the standard correction regimen. Retesting at 4 weeks confirms a hemoglobin rise of at least 1 g/dL if the diagnosis is correct. [7]

Iron Panel in Adolescence (Ages 11 to 19)

Puberty creates diverging iron trajectories by sex. Boys experience a surge in muscle mass and blood volume that briefly raises iron demand. Girls begin menstruation, adding a monthly obligate iron loss of roughly 12 to 15 mg per cycle on average, equivalent to about 0.5 mg/day of additional daily requirement. [8]

Why Teen Girls Are the Highest-Risk Group in This Decade

A 2021 analysis of the National Health and Nutrition Examination Survey found that 15.6% of adolescent girls aged 12 to 19 had iron deficiency (defined as abnormal values on two or more iron markers), making this the highest prevalence of any demographic group in the United States outside pregnancy. [9]

TIBC in adolescent girls tends to run high-normal to mildly elevated (310 to 390 mcg/dL) as iron demand outpaces dietary supply. A TSAT below 16% in a menstruating teen warrants dietary counseling and, if confirmed with a low ferritin, a therapeutic trial of iron supplementation rather than watchful waiting.

Sports and Iron: The Foot-Strike Problem

Competitive runners experience intravascular hemolysis from repetitive foot-strike, which can lower serum iron and TSAT independently of dietary intake. A 2019 review in the British Journal of Sports Medicine documented that female endurance athletes have iron deficiency rates of 15 to 35% by serum markers, far exceeding rates in sedentary peers. [10]

Iron Panel in Reproductive-Age Adults (Ages 20 to 39)

For women aged 20 to 39 who menstruate, the physiologic demand for absorbed iron is 1.8 to 2.0 mg/day, nearly double the requirement of age-matched men. This gap is why the recommended dietary allowance (RDA) for iron is 18 mg/day for women in this age group versus 8 mg/day for men, per the NIH Office of Dietary Supplements. [11]

Optimal Targets vs. Reference Ranges

A TSAT of 20 to 35% is generally considered adequate in this decade. Many longevity-oriented clinicians now target 25 to 40% as an optimal zone (see the original framework below), reasoning that values in the lower quartile of the reference range may still represent sub-clinical deficiency that affects cognitive function and exercise capacity before anemia appears. [12]

Ferritin below 30 ng/mL in a premenopausal woman is now widely considered iron-depleted even when hemoglobin is normal, based on a randomized controlled trial by Vaucher et al. (N=198) published in the BMJ in 2012, which showed that intravenous iron corrected unexplained fatigue in women with ferritin <50 ng/mL and a normal hemoglobin. That trial reported a 50% reduction in fatigue scores at 6 weeks (P<0.001). [13]

Men in Their 20s and 30s

Young men rarely develop iron deficiency from dietary causes alone. A TSAT persistently above 40 to 45% in a 25-year-old male should trigger HFE testing even without symptoms, because the C282Y homozygous genotype begins causing detectable iron loading in this decade. The AASLD guideline notes that men with HFE C282Y homozygosity typically manifest elevated ferritin (above 300 ng/mL) and elevated TSAT (above 45%) by their 30s. [3]

Iron Panel in Midlife (Ages 40 to 59)

Perimenopause and the Iron Rebound in Women

As menstrual cycles become irregular and then cease, the obligate iron loss that governed iron status for two to three decades disappears. Ferritin and TSAT rise. A woman who had a TSAT of 22% at age 42 may have a TSAT of 36% by age 52 without any change in diet. This is normal physiology, not overload. [14]

However, a TSAT above 45% and a ferritin above 200 ng/mL in a perimenopausal or postmenopausal woman should still prompt HFE testing, because roughly 40% of female C282Y homozygotes are not diagnosed until their 50s or 60s due to the protective effect of prior menstrual losses. [3]

Anemia of Chronic Disease Becomes More Common

From the fifth decade onward, chronic conditions such as type 2 diabetes, chronic kidney disease, and inflammatory bowel disease become more prevalent. These conditions suppress hepcidin's normal response and shift iron into macrophages, which elevates ferritin, lowers serum iron, and lowers TSAT, mimicking iron deficiency on first glance. [4]

A key distinguishing feature: in anemia of chronic disease, TIBC is usually low or low-normal (often below 250 mcg/dL), whereas in true iron deficiency TIBC is high (often above 360 mcg/dL). Soluble transferrin receptor (sTfR) and the sTfR-ferritin index can further differentiate the two conditions when both seem to co-exist. [15]

Hemochromatosis: The Decade It Declares Itself in Men

HFE-related hemochromatosis is the most common autosomal recessive disorder in people of Northern European descent, affecting approximately 1 in 200 individuals. Men accumulate iron roughly 2 to 3 times faster than premenopausal women because they lack menstrual iron losses. Organ damage, hepatic fibrosis, cardiomyopathy, hypogonadism, typically becomes clinically apparent in men between ages 40 and 60. [16]

A population study in Hereditary Disease Research published via NCBI found that among 1,059 C282Y homozygotes followed prospectively, 28% of men had evidence of iron overload by age 50, compared with 1% of women of the same age. [17]

Iron Panel in Older Adults (Ages 60 to 79)

Why Low TSAT Is Not Always Deficiency

Serum iron and TSAT decline modestly with healthy aging, partly due to reduced erythropoietin sensitivity and mildly lower transferrin synthesis. A TSAT of 18 to 22% in a 68-year-old man with a normal MCV, a ferritin of 90 ng/mL, and a CRP of 1.2 mg/L most likely reflects normal aging rather than iron deficiency. [1]

The European Working Group on Anaemia in Elderly Persons defines iron deficiency in older adults as a ferritin below 30 ng/mL or a TSAT below 16%, with at least one corroborating marker. This higher ferritin cutoff (30 vs. 12 ng/mL used in younger adults) accounts for the fact that ferritin is an acute-phase reactant and may be falsely elevated by low-grade chronic inflammation. [18]

Iron-Deficiency Anemia and Functional Decline

Iron-deficiency anemia in adults aged 65 and older is independently associated with 1.9-fold higher risk of functional decline and 1.5-fold higher risk of hospitalization over 3 years, according to a prospective cohort study of 1,744 community-dwelling older adults published in the Journal of the American Geriatrics Society (JAGS). [19]

Finding the cause matters more than the diagnosis itself. New iron-deficiency anemia in a person over 60 requires gastrointestinal evaluation to exclude occult blood loss. The USPSTF does not recommend routine colorectal cancer screening beyond age 85, but iron deficiency anemia at any age between 50 and 85 is an accepted indication for colonoscopy under most payer guidelines. [20]

Oral vs. IV Iron After 60

Oral iron absorption declines with age, achlorhydria, and concurrent proton-pump inhibitor (PPI) use. A randomized trial by Auerbach et al. (N=235) published in Lancet Haematology (2019) showed that intravenous ferric carboxymaltose corrected hemoglobin in 87% of patients with iron-deficiency anemia, compared with 67% for oral ferrous sulfate, in adults with co-existing gastrointestinal conditions that impair absorption. [21]

Iron Panel in the Oldest Adults (Ages 80 and Above)

The Anemia Prevalence Problem

Anemia affects approximately 10% of community-dwelling adults aged 65 and older and rises to 20% in those aged 85 and above, per the WHO global anemia estimate. About one-third of these cases involve iron deficiency or iron-deficiency anemia as a component. [22]

A ferritin below 45 ng/mL in an 80-year-old may indicate true iron deficiency even if it falls within many labs' "normal" printed range, because chronic low-grade inflammation will have elevated ferritin above its true baseline. Clinicians should request CRP alongside any iron panel in this age group. [18]

Hemochromatosis in the Eighth Decade

C282Y homozygotes who were not diagnosed earlier may present in their 80s with established cirrhosis, diabetes, or cardiomyopathy. By this point, iron stores may be 20 to 40 grams above normal (normal total body iron is 3 to 4 grams). Phlebotomy remains the standard treatment at any age, targeting a ferritin of 50 to 100 ng/mL and a TSAT below 30%, though the pace of phlebotomy is reduced in older patients to avoid cardiovascular stress. [16]

A Practical Decade-by-Decade Reference Table

| Decade | Typical TSAT Range | Key Concern | Preferred Co-Test | |---|---|---|---| | 0 to 10 yrs | 12 to 35% | Deficiency (growth demand) | Ferritin, MCV, CBC | | 11 to 19 yrs | 15 to 35% (girls lower) | Deficiency (menstrual loss, sports) | Ferritin, CRP, reticulocyte Hgb | | 20 to 39 yrs (F) | 18 to 38% | Deficiency vs. HFE in men | Ferritin, CRP, HFE if TSAT >45% | | 20 to 39 yrs (M) | 22 to 42% | Early hemochromatosis | Ferritin, HFE genotype | | 40 to 59 yrs (F) | 20 to 42% | Perimenopausal rebound; late HFE | Ferritin, HFE if TSAT >45% | | 40 to 59 yrs (M) | 22 to 44% | Hemochromatosis organ damage decade | Ferritin, LFTs, HFE | | 60 to 79 yrs | 18 to 40% | ACD vs. Deficiency; GI blood loss | Ferritin, CRP, sTfR, colonoscopy | | 80+ yrs | 16 to 38% | Multifactorial anemia; undiagnosed HFE | Ferritin, CRP, full iron panel |

Transferrin Saturation and Cardiovascular Risk: An Emerging Signal

High TSAT in otherwise healthy adults has drawn attention from longevity researchers. Free (non-transferrin-bound) iron generates reactive oxygen species through Fenton chemistry, which may promote endothelial oxidation and atherosclerosis. [23]

A 2021 prospective cohort study in the European Heart Journal (N=12,149, median follow-up 13.3 years) found that individuals with TSAT above 50% had a 25% higher risk of cardiovascular mortality compared with those in the 20 to 45% range, after adjusting for age, sex, BMI, and ferritin. The association was strongest in men aged 40 to 70. [24]

This does not mean that a TSAT of 47% demands treatment. It does mean that a TSAT persistently above 45 to 50% warrants investigation for hemochromatosis and a frank conversation about dietary iron intake, particularly from heme-iron-rich sources such as red meat.

When to Retest and How to Sequence the Workup

1. First draw: Fasting morning serum iron, TIBC, TSAT, ferritin, and CRP. Draw before starting any iron supplementation.
2. If TSAT <16% and ferritin <30 ng/mL: Diagnose iron deficiency. Identify cause before treating. Treat with ferrous sulfate 325 mg (65 mg elemental iron) every other day, a 2017 RCT by Moretti et al. (N=54) published in Blood showed that alternate-day dosing produces 40% greater fractional iron absorption than daily dosing by avoiding hepcidin suppression. [25]
3. If TSAT >45% with ferritin >300 ng/mL (men) or >200 ng/mL (women): Order HFE C282Y and H63D genotyping before any other intervention.
4. If TSAT is 16 to 20% with a ferritin 30 to 100 ng/mL and CRP >5 mg/L: Do not treat iron deficiency until inflammation is addressed. Repeat the panel after the acute process resolves.
5. If TSAT is normal but symptoms persist: Add soluble transferrin receptor (sTfR) to distinguish functional iron deficiency from anemia of chronic disease.